So, any compound or formulation which can act as an antioxidant as well as cholinesterase inhibitor may prove to be a better drug option for the treatment of AD, where oxidative stress and cholinesterase mechanism are involved. The gene discussed is BCHE; the disease is Alzheimer disease.